(Q52066927)

21 April 2018

title

Psychotropic drug prescription patterns among patients with bipolar I disorder. (English)

1 reference

21 April 2018

0 references

7

Kupfer DJ

1 reference

21 April 2018

author name string

Levine J

1

1 reference

21 April 2018

Chengappa KN

2

1 reference

21 April 2018

Brar JS

3

1 reference

21 April 2018

Gershon S

4

1 reference

21 April 2018

Yablonsky E

5

1 reference

21 April 2018

Stapf D

6

1 reference

21 April 2018

publication date

1 June 2000

1 reference

21 April 2018

published in

Bipolar Disorders

1 reference

21 April 2018

volume

2

1 reference

21 April 2018

issue

2

1 reference

21 April 2018

page(s)

120-130

1 reference

21 April 2018

Bipolar mood disorder: practical strategies for acute and maintenance phase treatment

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Individual aspects of physician and patient, and their impact on the prescription of psychotropic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Polypharmacy among psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Antidepressant prescribing practices of outpatient psychiatrists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Polypharmacy: correlations with sex, age and drug regimen. A prescription database study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Relapse and impairment in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Recurrence in affective disorder. II. Effect of age and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Women with bipolar illness: clinical and research issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

The relationship of premorbid personality to subtypes of an affective illness. A replication study by means of an operationalized procedure for the diagnosis of personality structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

The epidemiology of DSM-III-R bipolar I disorder in a general population survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Tranylcypromine versus imipramine in anergic bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Treatment of imipramine-resistant recurrent depression, IV: A double- blind crossover study of tranylcypromine for anergic bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Lithium discontinuation and subsequent effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Differential features between bipolar I and bipolar II disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Pharmacotherapy of Inpatients with Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

Trends in the prescription of antidepressants by office-based psychiatrists

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Diagnostic certainty of a voluntary bipolar disorder case registry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

A family study of bipolar II disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Mood disorder service genetic database: Morbidity risks for mood disorders in 3,942 first-degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar II

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Excess mortality of bipolar and unipolar manic-depressive patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Mortality in affective disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Outcome in manic disorders. A naturalistic follow-up study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Long-term therapy of affective disorders: monotherapy or polypharmacy?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

How effective is lithium in the prevention of relapse in bipolar disorder? A prospective naturalistic follow-up study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Antidepressant-induced mania and cycle acceleration: a controversy revisited

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Efficacy of lithium prophylaxis in clinical practice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Persistent tardive dyskinesia in bipolar patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Clozapine for treatment-refractory mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Clonazepam in acute mania: a double blind trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Long-term outcome of lithium prophylaxis in patients initially classified as complete responders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2000.020205.X

7 January 2021

10.1034/J.1399-5618.2000.020205.X

Identifiers

DOI

1 reference

21 April 2018

1 reference

21 April 2018